Las Vegas, NV
What Is BRAINWeek?
BRAINWeek will be September 28–30 at the Red Rock Casino, Resort & Spa in Las Vegas, NV. The national conference offers a practical, expansive CME agenda designed for a multidisciplinary audience of specialists and frontline practitioners managing CNS disorders.
Developed by the PAINWeek organization, BRAINWeek officially launched in May 2021 as a live virtual conference addressing the most frequently diagnosed conditions encountered in clinical practice, with an emphasis on collaborative care among specialists and front-line practitioners. Approximately 700 practitioners and 20 participating sponsors/societies participated in the conference. The agenda presented CME/CE certified activities on movement and neurodegenerative disorders (MS and Parkinson’s disease), migraine, dementia, stroke, and the impact of COVID-19 on CNS disorders.
CE/CME Credit Hours
Topic Areas Covered
Featured BRAINWeek Course
ROOM WITHOUT A VIEW:
MEETING THE INCREASED DEMAND FOR MENTAL HEALTH TREATMENT DURING COVID-19
The catastrophic health effects of the coronavirus pandemic are well established, as illustrated by the more than 32 million known cases and over 570,000 COVID-19-related deaths in the United States to date. What has also become more apparent is the immense psychological impact. As a result of the pandemic, much of society is experiencing increased stress in relation to numerous psychosocial factors. This session speaks to the need for increased mental health resources to cope with anxiety and fear about contracting the virus, increased social isolation, separation from family, job loss, economic uncertainty, and grieving the loss of a loved one to the disease.
This activity is supported by an educational grant from Allergan.
“The current estimated annual cost to American society of just nine of the most common neurological diseases is staggering, totaling $789 billion. These conditions include Alzheimer’s disease and other dementias, low back pain, stroke, traumatic brain injury, migraine, epilepsy, multiple sclerosis, spinal cord injury, and Parkinson’s disease.”
Gooch CL, Pracht E, Borenstein AR. The burden of neurological disease in the United States: a summary report and call to action. Ann Neurol. 2017;81:479-484.